Company attributes
Other attributes
Owlstone Medical is developing a breathalyzer for disease, with a focus on non-invasive diagnostics for the early detection of disease and on precision medicine, initially targeting lung cancer, liver disease, digestive health, and respiratory disease. The company’s stated mission is to save 100,000 lives and $1.5B in healthcare costs.
The Company’s Breath Biopsy® platform includes ReCIVA®, a proprietary sample collection device that can take stable breath samples anywhere. The company's commercial Breath Biopsy Laboratory is located in Cambridge, U.K., with support through an office in Research Triangle Park, NC, USA, and the development of the world’s largest Digital Breath Biobank matched to patient phenotype.
Owlstone Medical's ReCIVA Breath Sampler
